http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2010140598-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-10
filingDate 2009-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2012-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2010140598-A
titleOfInvention SPIRINE DERIVATIVES PARTENIN AS NEW ANTI-CANCER AGENTS
abstract 1. Spiro derivatives of partinin with the general structural formula 1:! ! where the X values are selected from the group consisting of nitrile oxide, nitron and azide. ! 2. The derivatives of claim 1, wherein said spiro derivative is spiroisoxazoline having the general structural formula 1a: !! where R is selected from the group consisting of hydrogen, alkyl substituents, namely methyl, ethyl, propyl and their higher homologues, linear or branched, including alicyclic, such as cyclopentane, cyclohexane or rings with a higher content of members, condensed rings, alkyl groups substituted with aryl / heteroaryl, including the benzyl group or its higher homologues, which may include unsaturated alkyl groups, such as cinnamyl, crotyl, prenyl substituents; and R may also be an aryl substituent in the first position of the isoxazoline ring of structure 1a, namely, substituted phenyl, with the exception of 3,4-methylenedioxyphenyl, naphthyl, anthracenyl, phenanthrenyl or other heteroaromatic ring systems such as pyridinyl, indolyl, benzofuryl, furyl , theophenyl, oxazolyl, isoxazolyl or any other single or fused ring heteroaromatic system. ! 3. The derivative of claim 1, wherein said spiro derivative is a spiroisoxazolidine derivative having the general structural formula 1b:! ! where the R / R 'value is selected from the group consisting of hydrogen, alkyl substituents, namely methyl, ethyl, propyl and their higher homologues, linear or branched, including alicyclic, such as cyclopentane, cyclohexane or rings containing higher
priorityDate 2008-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25423
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397535
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17888360
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397538
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394672
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416067472
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID720071
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID241
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394667
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457626896
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394720
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456373471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394669
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419589583
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484319
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559478
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID242
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419568867
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559294
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394759
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33558
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393351
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397831
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12220
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394673
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394780
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9253
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456922693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456033880
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394775
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8078
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24823
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID442288
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415967005
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451203358
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559219
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394678
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394671
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420166489
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394796
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394719
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484729
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559473
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393346
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456370552
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559500

Total number of triples: 72.